CCT68127
CCT68127 is an orally active CDK inhibitor. CCT68127 can be used in anti-cancer research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 660822-23-1
- Formel: C19H27N7O
- Molecular Weight:369.46
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
CDK2 |
CDK7 |
CDK9 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
1.3 μM
Compound: alphaSbetaR-21, CCT68127
|
Inhibition of CDK7 in human HT29 cells assessed as reduction in RNA polymerase 2 expression
Inhibition of CDK7 in human HT29 cells assessed as reduction in RNA polymerase 2 expression
|
[PMID: 21982796] |
| HT-29 | IC50 |
107 nM
Compound: alphaSbetaR-21, CCT68127
|
Inhibition of CDK9 in human HT29 cells assessed as reduction in RNA polymerase 2 expression
Inhibition of CDK9 in human HT29 cells assessed as reduction in RNA polymerase 2 expression
|
[PMID: 21982796] |
Chemical Information
-
CAS. Nr. 660822-23-1
-
Molecular Weight 369.46
-
Formel C19H27N7O
-
SMILES
C[C@@H](O)[C@@H](NC1=NC(NCC2=CC=CN=C2)=C3N=CN(C(C)C)C3=N1)CC
-
Synonyms
αSβR-21
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)